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This  work  reports  for  the  ﬁrst  time  an  electrochemical  immunosensor  for the determination  of  adreno-
corticotropin  hormone  (ACTH).  The  immunoelectrode  design  involves  the  use  of  amino  phenylboronic
acid  for  the  oriented  immobilization  of  anti-ACTH  antibodies  onto  screen-printed  carbon modiﬁed  elec-
trode  surfaces.  A competitive  immunoassay  between  the antigen  and  the  biotinylated  hormone  for  the
binding  sites  of  the  immobilized  antibody  was  performed.  The  electroanalytical  response  was  generated
by using  alkaline  phosphatase-labelled  streptavidin  and  1-naphtyl  phosphate  as the enzyme  substrate.drenocorticotropin hormone
henyl boronic acid
lectrochemical immunosensor
The  electrochemical  oxidation  of  the  enzyme  reaction  product,  1-naphtol,  measured  by  differential  pulse
voltammetry  was  employed  to monitor  the afﬁnity  reaction.  Under  the  optimized  working  conditions,
an  extremely  low  detection  limit  of  18 pg/L  was  obtained.  Cross-reactivity  was  evaluated  against  other
hormones  (cortisol,  estradiol,  testosterone,  progesterone,  hGH  and  prolactin)  and  the  obtained  results
demonstrated  an  excellent  selectivity.  The  developed  immunosensor  was  applied  to  a  human  serum
sample  containing  a certiﬁed  amount  of ACTH  with  good  results.. Introduction
Human adrenocontocotropin hormone (ACTH) is a peptide with
9 amino acids, 4500 Da, obtained by enzymatic cleavage of a
recursor, the pro-opiomelanocortin (POMC) synthesized in the
nterior pituitary (Yalow and Berson, 1971; Guillemin et al., 1977).
he main function of the hormone is the induction of the synthesis
f corticoids, especially cortisol. Levels of ACTH in serum ﬂuctuate
etween <4.1 and 51.4 ng/L (Talbot et al., 2003) with the higher lev-
ls in the early morning and the lower levels in the evening (Norton
t al., 2001). Several factors such as stress, pain, trauma, hypoxia,
ypothermia and hypoglucemia can increase the concentration of
CTH in serum. The determination of ACTH levels in plasma is a
ey step in the diagnosis of pituitary Cushing’s syndrome, adreno-
ortical insufﬁciency (Addinson’s disease), hypopituitarism, and
ituitary tumors (Talbot et al., 2003). Furthermore, the admin-
stration of ACTH is banned by the World Antidoping Agency
WADA) because it stimulates corticosteroid production and gen-
rates euphoria (Thevis et al., 2006). Various immunoassays havePlease cite this article in press as: Moreno-Guzmán, M., et al., Biosens. Bioe
een proposed in the literature for the determination of ACTH using
ifferent antibodies and radioactivity, chemiluminiscence or ﬂu-
rescence as detection techniques. These methods were claimed
∗ Corresponding author. Fax: +34 913944329.
E-mail address: yseo@quim.ucm.es (P. Yán˜ez-Seden˜o).
956-5663/$ – see front matter ©  2012 Elsevier B.V. All rights reserved.
oi:10.1016/j.bios.2012.02.015© 2012 Elsevier B.V. All rights reserved.
to be suitable to cover ranges between a few units up to vari-
ous hundreds of ng/L ACTH (Talbot et al., 2003; Brossaud et al.,
2011; Vogeser et al., 2000; Dobson et al., 1987). However, to our
knowledge, no immunosensors for the determination of ACTH are
described at present in the literature.
In particular, electrochemical immunosensors have demon-
strated to gather useful analytical characteristics such high
sensitivity, rapid response and easiness of use (Fowler et al.,
2008). A crucial aspect in the design of these bioelectrodes is
the combination of immobilization methods able to improve the
immunoreagent stability and favourable orientation with a high
electroanalytical performance. In this sense, various approaches
have been described in the literature including the use of nanos-
tructured electrode surfaces (Carralero et al., 2007; Wang, 2007;
Pingarrón et al., 2008), self-assembled monolayers (Arya et al.,
2009; Hao et al., 2007), or magnetic particles (Centi et al., 2007;
Tang et al., 2010; Eguílaz et al., 2010). Another strategy that has
demonstrated its usefulness for this purpose is the use of boronic
acids which interact with sugars to form cyclic boronate esters at
room temperature (Abad et al., 2002). This kind of binding reaction
can be also successfully employed for the orientation of antibody
molecules onto an electrode surface (Ho et al., 2011).lectron. (2012), doi:10.1016/j.bios.2012.02.015
In this paper, we  report the construction of an electrochem-
ical immunosensor enabling the ultrasensitive determination of
ACTH. The immunosensor design involves the combination of
phenylboronic acid-modiﬁed screen-printed carbon electrodes,
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o efﬁciently immobilize ACTH antibodies, with a competitive
mmunoassay involving biotinylated ACTH, and a differential pulse
oltammetric detection step using alkaline phosphatase-labelled
treptavidin and 1-naphthyl phosphate (1-NPP) as enzyme sub-
trate.
. Experimental
.1. Reagents and solutions
A 1.05 mg/mL  stock solution of anti-ACTH C-terminal (Fitzger-
ld, MA,  USA) was prepared by suitable dilution with 0.05 M
hosphate buffer solution of pH 7.4 (PBS). Biotinylated ACTH
Biotin-ACTH) was obtained from AnaSpec, CA, USA, and 1.0 mg/mL
olutions were prepared by dilution with distilled water. More
iluted solutions were prepared by dilution with PBS. A stock
.0 mg/mL  alkaline phosphatase-labelled streptavidin (Strept-AP)
Sigma) solution was prepared in Tris–HCl buffer of pH 7.2, and
ore diluted solutions were prepared in the same buffer. A stock
.0 mg/mL  solution of ACTH from Genway Biotech, CA, USA was
repared in water and stored at −40 ◦C until use. More diluted
olutions were prepared by dilution with PBS. 2% (w/v) bovine
erum albumin (BSA, Type H2, Gerbu) solutions were prepared
n PBS. A Trizma base (Sigma, 99%) and 1 mM magnesium chlo-
ide (Panreac, 99%) buffer solution of pH 9.0 (Trizma buffer),
as also employed. 0.05 M solutions of 1-NPP (Fluka) were pre-
ared by dilution with Trizma buffer. 4-Aminobenzoic acid (ABA,
cross), 3-aminophenylboronic acid (APBA, Sigma), 1-Ethyl-3-[3-
imethylaminopropyl]carbodiimide hydrochloride (EDC, Sigma)
nd N-hydroxysuccinimide (NHS, Sigma), were also used. For
he cross-reactivity assays, cortisol, testosterone, -estradiol, pro-
esterone, human growth hormone (hGH), all from Sigma, and
rolactin (Immunometrics, UK), were tested.
All chemicals were of analytical-reagent grade and the water
sed was obtained from a Milli-Q puriﬁcation system (Millipore,
edford, NA, USA).
.2. Samples
A certiﬁed sample of lyophilized human serum from NIBSC,
4/555, where each ampoule contained the freeze-dried residue of
.5 mL  of a solution which contained 25 g ACTH was  analyzed. The
olid was reconstituted in distilled water for a ﬁnal concentration
f 10 g/mL ACTH.
.3. Apparatus and electrodes
All electrochemical measurements were carried out using a
GSTAT 12 potentiostat from Autolab. The electrochemical soft-
are was the general-purpose electrochemical system (GPES)
EcoChemie B.V.). Screen-printed carbon electrodes (4 mm  diam-
ter) were purchased from DropSens (Oviedo, Spain) and used
s the working electrodes. These electrodes include a silver
seudo-reference electrode and a carbon counter electrode. All
xperiments were performed at room temperature. A P-Selecta
ltrasonic bath, an Optic Ivymen System constant temperature
ncubator shaker (Comecta S.A.), and a P-Selecta Agimatic mag-
etic stirrer, all distributed by Scharlab, Madrid, Spain, were also
sed.
.4. ProceduresPlease cite this article in press as: Moreno-Guzmán, M., et al., Biosens. Bioe
.4.1. Preparation of aminophenylboronic acid-modiﬁed
creen-printed carbon electrodes (APBA–SPCEs)
Screen-printed carbon electrodes were modiﬁed with
minophenylboronic acid by means of a two step procedure. PRESS
 Bioelectronics xxx (2012) xxx– xxx
Firstly, 20 mg  of ABA were dissolved in 2 mL  of 1 M HCl and
cooled with ice. Then, the diazonium salt was prepared by
adding 2 mM NaNO2 aqueous solution dropwise to this solu-
tion (38 L for each 200 L) with constant stirring. Next, 40 L
from the resulting solution was placed onto the SPCE and ten
successive voltammetric cycles ranging between 0.0 and −1.0 V
( = 200 mV/s) were carried out. The modiﬁed electrodes were
washed thoroughly with water and methanol and dried at room
temperature. In a second step, 10 L from an EDC/NHS (0.1 M
each) aqueous solution were placed onto the modiﬁed electrode
and left to react for 1 h. After rinsing with water and methanol
and drying, 10 L from a 50 mM APBA were placed onto the
electrode. After 3 h, the resulting aminophenylboronic elec-
trode (APBA/SPCE) was  rinsed with water and methanol, and
dried.
2.4.2. Preparation of the ACTH immunosensor
10 L of a 30 g/mL anti-ACTH solution in PBS were dropped
onto the APBA/SPCE and left to stand overnight. Then, 10 L
of a 2% BSA blocking solution were deposited onto the anti-
ACTH/APBA/SPCE and left to incubate for 1 h. In order to perform the
competitive assay, 10 L of a mixture of the appropriate standard
ACTH solution (or the sample) and 750 ng/mL Biotin-ACTH were
placed onto the electrode surface and incubated for 45 min  at 8 ◦C.
Subsequently, 10 L of 2000 ng/mL Strept-AP was added and, after
60 min, 45 L of Trizma buffer plus 5 L of 0.05 M 1-NPP solution
were deposited onto the electrode and allowed to stand for 8 min.
Differential pulse voltammograms were recorded over the −0.15
to +0.60 V potential range.
2.4.3. Sample analysis
Glass ampoules containing lyophilized serum samples were
stored at −40 ◦C. When used, the solid from each ampoule was
reconstituted in 2.5 mL  distilled water at 20 ◦C by gentle stirring and
mixing up to total dissolution. ACTH determination was  performed
by applying the procedure described above, and the peak current
values measured by DPV were interpolated into the linear portion
of the calibration plot obtained with ACTH standard solutions.
3. Results and discussion
The fundamentals of the developed immunosensor are illus-
trated in Fig. 1. Firstly, SPCEs were modiﬁed with boronic acid
according to the procedure by Ho et al. (2011) with slight changes.
Brieﬂy, diazotation of ABA was performed with sodium nitrite in
hydrochoride acid, the resulting 4-carboxybenzenediazonium ion
solution was dropped onto the SPCE surface and the potential was
cycled as described in Section 2. Fig. 2 shows the Nyquist plots
obtained by electrochemical impedance spectroscopy using 5 mM
Fe(CN)64−/Fe(CN)63− as redox probe in 0.1 M KCl. As it can be seen,
modiﬁcation of the SPCE with ABA gave rise to a large increase in
the electron transfer resistance (RCT = 3050 ) as a consequence of
the electrostatic repulsion between the redox probe and the neg-
atively charged carboxylate groups. Thereafter, surface-conﬁned
carboxyl groups were activated with EDC/NHS and APBA moieties
were attached to the electrode surface trough the formation of
amide bonds. This modiﬁcation with APBA produced a dramatic
decrease in the RCT value (307 )  due to the neutralization of the
electrode negative surface charge. Then, anti-ACTH antibodies were
attached to the resulting APBA/SPCE through the oriented boronic
acid-saccharide bonds. After a blocking step with BSA, a compet-lectron. (2012), doi:10.1016/j.bios.2012.02.015
itive assay between ACTH and biotinylated ACTH for the binding
sites of the immobilized antibodies was  accomplished. Strept-AP
was used to detect the immunosensing event by adding 1-NPP as
AP substrate and measuring the electrochemical oxidation of the
ARTICLE IN PRESSG ModelBIOS-4992; No. of Pages 5
M. Moreno-Guzmán et al. / Biosensors and Bioelectronics xxx (2012) xxx– xxx 3
F t of dis
m
g
p
3
i
i
l
m
a
A
r
F
w
r
s
i
I
e
a
i
s
F
(
aig. 1. Schematic display of the reactions and protocols involved in the developmen
odiﬁed with phenylboronic acid.
enerated enzyme reaction product, 1-naphtol, by differential
ulse voltammetry.
.1. Optimization of the experimental variables involved in the
mmunosensor response to ACTH
All variables involved in the analytical performance of the
mmunosensor for ACTH were optimized. Firstly, the antibody
oading onto the APBA/SPCE was evaluated by checking the voltam-
etric response obtained with different immunosensors, in the
bsence of ACTH, constructed upon deposition of 10 L of anti-
CTH solution prepared in the 5–40 g/mL antibody concentration
ange, and using 750 ng/mL Biotin-ACTH and 1 g/mL Strept-AP.
ig. S1 (suppl. material) shows as the measured ip value increased
ith the antibody loading up to 30 g/mL reaching a saturated
esponse for larger loadings. Therefore, 30 g/mL anti-ACTH was
elected for further work to attain the highest possible sensitiv-
ty. Anti-ACTH–APBA/SPCEs were allowed to stay overnight at 8 ◦C.
n order to avoid non-speciﬁc binding of immunoreagents on thePlease cite this article in press as: Moreno-Guzmán, M., et al., Biosens. Bioe
lectrode surface (Wang et al., 2008), a blocking step with BSA was
ccomplished. Accordingly, both the BSA concentration and the
ncubation time employed to block the free sites on the electrode
urface were also optimized. The protocol consisted of dropping
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ig. 2. Nyquist plots recorded from a 5 mM [Fe(CN)6]3−/4− 0.1 M KCl solution at
a)  bare SPCE, (b) 4-aminobenzoic acid-modiﬁed SPCE, (c) 3-aminophenylboronic
cid-modiﬁed SPCE.posable electrochemical immunosensors for ACTH using screen-printed electrodes
10 L of 1, 2 or 5% BSA solutions, which were allowed to stand for
30, 60 or 120 min, onto the APBA/SPCEs and measuring the ip val-
ues in the presence of 1500 ng/mL Biotin-ACTH and 2000 ng/mL
Strept-AP. The obtained results (not shown) led us to choose a 2%
BSA concentration and an incubation time of 60 min at room tem-
perature as the optimum experimental conditions. Under these
conditions unspeciﬁc responses were found to be always lower
than 10% of the signals obtained with the Strept-AP–Biotin-ACTH-
anti-ACTH–APBA/SPCE.
Another optimized variable was the concentration of Biotin-
ACTH. In order to do that, different Strept-AP–Biotin-ACTH-anti-
ACTH–APBA/SPCE immunosensors were prepared by incubating
in Biotin-ACTH solutions with concentrations ranging in the
0–1500 ng/mL concentration range. The ip values measured with-
out ACTH showed an important increase from 0 to 750 ng/mL and
a slight decrease for higher Biotin-ACTH concentrations (Fig. S2).
Thus, 750 ng/mL was  the selected value for further work. Moreover,
the incubation time in the Biotin-ACTH solution was  also evaluated
in the 0 to 60 min interval by testing the voltammetric sig-
nal obtained with Strept-AP–Biotin-ACTH-anti-ACTH–APBA/SPCE
immunosensors for 1 ng/mL ACTH. The largest peak current (results
not shown) was obtained for 45 min  and therefore, this was selected
as the incubation time to be used. The effect of temperature in
the incubation step was  also investigated by recording DP voltam-
mograms with immunosensors which were incubated at 8 ◦C, at
room temperature, and at 38 ◦C. The obtained results (not shown)
revealed that both the peak current and the reproducibility of the
voltammetric responses decreased as the temperature increased,
probably due to the lower stability of ACTH (Talbot et al., 2003).
Thus, incubation in the Biotin-ACTH immunoreagent was accom-
plished at 8 ◦C.
In order to perform the competitive assay, Strept-AP was
used. The conjugate concentration was optimized by testing the
voltammetric response of different immunosensors incubated
with Strept-AP in the 0 to 2000 ng/mL range. The obtained results
(Fig. S3)  revealed a regular current increase up to 1500 ng/mL
whereas the peak current remained practically constant for largerlectron. (2012), doi:10.1016/j.bios.2012.02.015
conjugate concentrations. Therefore, 1500 ng/mL probably corre-
sponded to saturation of the biotinylated ACTH with Strept-AP.
Accordingly, in order to achieve the optimal experimental condi-
tions to detect the competition between ACTH and Biotin-ACTH
ARTICLE IN PRESSG ModelBIOS-4992; No. of Pages 5
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metric response for 5 mM 1-NPP in the absence of ACTH. Fig. 5
shows the results obtained during a period of time of 27 days for
APBA/SPCE modiﬁed electrodes () and anti-ACTH–APBA/SPCE
0
5
10
15
0 5 10 15 20 25 days
i p
, 
µ
Aig. 3. Calibration plot for ACTH obtained with the Strept-AP–Biotin-ACTH-anti-
CTH–APBA/SPCE immunosensor. Open points correspond to the serum sample
nalysis.
or the anti-ACTH binding sites, a concentration of 2000 ng/mL
trept-AP was selected. Moreover, the incubation step was  found
o provide optimum results when it was carried out at 8 ◦C for
0 min  (results not shown).
Furthermore, the voltammetric behaviour at the SPCE of differ-
nt phenolic compounds (indoxyl, 4-aminophenol and 1-naphtol),
hich can be generated as alkaline phosphatase reaction products
rom their respective phosphate derivatives used as enzyme sub-
trates, was checked. Cyclic voltammograms from 5.0 mM solutions
f these phenolic compounds in Trizma buffer of pH 9.0 (results not
hown) showed that the 1-naphthol irreversible oxidation reac-
ion occurred at a remarkably less positive potential than those
bserved for the other compounds. Although the peak current mea-
ured for 1-naphthol was slightly lower than that obtained for the
ther phenolics, as a compromise between sensitivity and selec-
ivity, 1-NPP was selected as the enzyme substrate to be used in
his work. The inﬂuence of 1-NPP concentration on the differential
ulse voltammetric responses of the Strept-AP–Biotin-ACTH-anti-
CTH–APBA/SPCE immunosensor is shown in Fig. S4.  As it can be
een, the highest peak current value was obtained at 5 mM 1-NPP,
hich represents a relatively high concentration then ensuring
hat the enzyme reaction rate depended only on the enzyme
oncentration.
.2. Analytical characteristics of the immunosensor for ACTH
Fig. 3 shows the calibration plot constructed for ACTH under the
ptimized working conditions stated above. Error bars displayed
ere calculated from measurements carried out with three differ-
nt immunosensors, except in the case of the points corresponding
o the absence of ACTH and in the EC50 value, where eight measure-
ents were made (see below). The calculated errors were below
0% in all cases. The ACTH concentration tested ranged between
0−3 and 500 pg/mL ACTH. The ip vs. ACTH concentration curve was
tted by non-linear regression using the Sigma Plot data analysis
oftware (Coneely et al., 2007). The adjusted equation (r = 0.995)
as:
p = imax − imin1 + EC50/x
+ iminPlease cite this article in press as: Moreno-Guzmán, M., et al., Biosens. Bioe
here imax and imin were the maximum and minimum peak cur-
ent values of the calibration graph: 8.3 ± 0.2 A and 1.5 ± 0.2 A,
espectively. The EC50 value, which is the ACTH concentration cor-
esponding to a ﬁfty per cent competition, was 0.10 ± 0.02 pg/mL,Fig. 4. Differential pulse voltammograms recorded with the Strept-AP–Biotin-
ACTH-anti-ACTH–APBA/SPCE immunosensor for 0 (1), 0.05 (2), 0.50 (3), and 1.00
(4)  pg/mL ACTH.
and the Hill slope, h, was −1.16 ± 0.15. The observed range of lin-
earity ranged between 0.025 and 1.0 pg/mL (r = 0.990), which is
adequate for the analysis of clinical samples. A very low limit of
detection, 18 pg/L ACTH was calculated from the equation:
LOD = EC50
(
imax − imin
imax − imin − 3s
− 1
)−1/h
where s is the standard deviation (n = 10) of the zero value (the ip
value measured in the absence of ACTH), ±0.28 A.
As an example of the voltammetric curves recorded, Fig. 4 dis-
plays the responses obtained for 0, 0.05, 0.50 and 1.00 pg/mL ACTH.
It can be observed as concentrations of the hormone as low as
0.05 pg/mL yielded very good DP voltammetric signals.
The reproducibility of the DP voltammetric measurements was
evaluated by carrying out assays with different immunosensors
both for solutions containing no ACTH and for a 0.10 pg/mL
(the EC50 value) ACTH concentration level on the same day and
on different days. Relative standard deviation (RSD) values of
3.3 and 4.4% (n = 8) were obtained, respectively, for the assays
performed on the same day, whereas the RSD values (n = 8) were
8.9% when no ACTH was  present and 5.9% for 0.10 pg/mL ACTH
when the measurements were carried out on different days. The
storage stability of the APBA/SPCE modiﬁed electrodes, as well as
that of anti-ACTH–APBA/SPCE and Strept-AP–Biotin-ACTH-anti-
ACTH–APBA/SPCE immunosensors was  also investigated. In order
to do that, the different modiﬁed electrodes and immunosensors
were prepared on the same day and stored in a refrigerator at
4 ◦C. Then, every electrode and bioelectrode was used to construct
the corresponding immunosensor and to measure the voltam-lectron. (2012), doi:10.1016/j.bios.2012.02.015
Fig. 5. Control chart constructed for APBA/SPCE () and anti-ACTH–APBA/SPCE (©).
Each point corresponds to the mean value for three successive measurements of
5  mM 1-NPP.
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Table  1
Cross-reactivity calculated from the EC50 values for different hormones with the
Strept-AP–Biotin-ACTH-anti-ACTH–APBA/SPCE immunosensor.
Compound EC50 (ng/mL) CRa (%)
ACTH 1.0 × 10−4 100
Cortisol 0.47 0.02
Prolactin 1.11 0.01
Estradiol 13,733 7.3 × 10−7
Testosterone >20,000 <5.0 × 10−7
Progesterone >20,000 <5.0 × 10−7
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Rapid Commun. Mass Spectrom. 20, 3551–3556.hGH >20,000 <5.0 ×10−7
%CR = 100 (EC50) ACTH/(EC50) interfering compound.
mmunosensors (©). Each point in the displayed control chart cor-
esponded to the mean value of three successive measurements.
s it can be seen, the APBA/SPCE modiﬁed electrodes yielded
oltammetric responses that remained inside the control limits
et at ±3 s calculated for the whole series of experiments, for at
east 18 days. However, a 63% of the initial current was observed
n the 27th day. On the other hand, the DPV responses measured
ith anti-ACTH–APBA/SPCE immunosensors remained inside the
ontrol limits for 15 days and the current measured on the 21st
ay corresponded to 83% of the initial value. Regarding the bioelec-
rode containing all the bioconjugates used in the immunosensor
unctioning, Strept-AP–Biotin-ACTH-anti-ACTH–APBA/SPCE, its
torage stability was much poorer retaining only a 30% of the
nitial value after ﬁve days from its preparation.
.3. Cross-reactivity
Various hormones (cortisol, testosterone, -estradiol, proges-
erone, human growth hormone (hGH), and prolactin) which may
e present in biological ﬂuids together with ACTH, were tested as
otential interfering substances for the immunosensor response
owards ACTH. The cross-reactivity was calculated from the EC50
alue for each tested compound and the obtained results are sum-
arized in Table 1. As it can be observed, all the tested species gave
ery low % CR, with values lower than 0.01% except in the case of
ortisol (0.02%). These results demonstrated the high selectivity of
he developed immunosensor.
.4. Determination of ACTH in certiﬁed serum samples
The usefulness of the immunosensor for the analysis of real
amples was checked by analyzing a certiﬁed human serum sam-
le. Calibration graphs were constructed from the reconstituted
ample which was appropriately diluted to obtain 0.05, 0.10,
.25 or 0.50 pg/mL ACTH. Fig. 3 shows this calibration graph
uperimposed on the calibration curve for ACTH obtained with
tandards. Errors bars were calculated in all cases for three differ-
nt measurements. As it can be observed, the analytical responses
verlapped completely in both calibration plots, with a linear por-
ion for the calibration recorded with the serum sample exhibiting
 slope value of −1.54 A (r = 0.997) which was  very similar to
hat obtained for ACTH standard solutions (−1.52 A; r = 0.990).
herefore, the determination of ACTH could be accomplished
y interpolation of the measured ip values into the calibration
lot obtained with ACTH standard solutions. The results obtained
or the analyses carried out at the four concentration levelsPlease cite this article in press as: Moreno-Guzmán, M., et al., Biosens. Bioe
entioned above were 0.050 ± 0.001, 0.11 ± 0.02, 0.23 ± 0.02 and
.49 ± 0.015 pg/mL ACTH for ﬁve replicates, with recoveries rang-
ng between 92 ± 3 and 106 ± 4%. These results demonstrated the
sefulness of the developed immunosensor for the analysis of low PRESS
 Bioelectronics xxx (2012) xxx– xxx 5
ACTH concentrations in human sera with practically no sample
treatment.
4. Conclusions
In this paper, the development of an electrochemical
immunosensor for ACTH is reported for the ﬁrst time. The
immunosensing approach involves the immobilization of anti-
ACTH onto phenylboronic acid-modiﬁed screen-printed carbon
electrodes and a competitive immunoassay implying biotinylated
ACTH and alkaline phosphatase labelled streptavidin. Moreover,
a differential pulse voltammetric analytical response was used to
monitor the afﬁnity reaction. The developed design exhibits an
excellent analytical performance in terms of sensitivity, selectivity,
wide range of quantiﬁable antigen concentrations, and inter-assay
reproducibility. Therefore, this immunosensor can be envisaged as
a useful and affordable analytical tool for the rapid determination
of ACTH in clinical applications, as it has been outlined with the
results obtained for the analysis of certiﬁed human serum samples.
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Fig. S1. Effect of the immobilized anti-ACTH loading on the DPV peak 
current measured with Strept-AP–Biotin-ACTH-anti-ACTH–APBA/SPCE 
immunosensors. See text for other conditions.
8
A
4
6
i
p
,
 
µ
A
0
2
0 10 20 30 40 50
anti-ACTH, µg/mL
Figure S1
Fig. S2. Effect of the Biotin-ACTH concentration on the DPV peak current 
measured with Strept AP Biotin ACTH anti ACTH APBA/SPCE
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Fig. S3. Effect of the Streptavidin-AP concentration on the DPV peak current measured 
with Strept-AP–Biotin-ACTH-anti-ACTH–APBA/SPCE immunosensors. See text for      
other conditions.
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Fig. S4. Effect of the 1 NPP concentration on the DPV peak current measured with 
Strept-AP–Biotin-ACTH-anti-ACTH–APBA/SPCE immunosensors. See text for other 
conditions.
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